S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
RGNT$1.43+4.38%
Regentis Biomaterials Ltd.
Sector: Orthopedic, Prosthetic & Surgical Appliances & SuppliesIndustry: Medical - Instruments & SuppliesCountry: ILExchange: NYSE
Mkt Cap:$10.04M
Float & O/S:
Inst Own:
DilutionScan read 40 of REGENTIS BIOMATERIALS LTD.'s SEC filings and found 10 warrant series, 3 convertibles, 3 S-1 registrations and 2 completed offerings on file for RGNT. The latest dilution event on file is a registration statement on Jul 13, 2026. Analysis updated Oct 4, 2026.
Signal8 Summary
RGNT
Unprofitable micro-cap near 52-week low
Snapshot
Regentis is a tiny, unprofitable biotech company with a $17.5M market cap. The stock is trading near its 52-week low at $1.28, down 84.7% from its high of $8.35. The company has no revenue and reports massive losses, with an EPS of -$24.16.
What's Happening Right Now
- : Regentis plans to start training European surgeons for its GelrinC knee implant in Q3 2026, accelerating commercial rollout in the EU where it already has approval.
- : Regentis reported that its pivotal FDA study for GelrinC in the US has completed over 50% of patient enrollment, targeting a $3 billion market.
- : The company patented a new solvent-free manufacturing process that increases GelrinC production yield by 400%, a key step before the European launch.
Raise routes on file: effective S-1 · latest dilution event 113 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jul 13, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
S-1 · primary offering
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your RGNT trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
